Therapeutic Segment: Anti-Diabetic
Generic Name: Dapagliflozin + Metformin
Daplyza-M (Dapagliflozin + Metformin HCl) is indicated in adults for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise:
• In patients insufficiently controlled on their maximally tolerated dose of Metformin HCl alone.
• In combination with other medicinal products for the treatment of diabetes in patients insufficiently controlled with Metformin HCl and these medicinal products.
• In patients already being treated with the combination of Dapagliflozin and Metformin HCl as separate tablets.
You are about to be redirected to an online retailer’s website. Getz Pharma is not liable for any data exchange on the new website
You will be redirected in 3secs
Disclaimer: "This message (including attachment) is intended solely for the use of the individual or entity whom it is addressed and may contain information that is confidential or privileged. If you are not the intended recipient of this message, you are hereby notified that any use, dissemination, distribution or reproduction of this message is prohibited and that, you must not take any action in reliance on it. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrived incomplete or contain viruses; therefore Getz Pharma (Private) Limited cannot accept legal responsibility for the contents of this message. If you have received this communication in error, please notify the sender or Getz Pharma (Private) Limited at [email protected] immediately and destroy the original message."Close